Vaxart (STU:NB11) 10-Year Share Buyback Ratio : -68.30% (As of Dec. 2024)

View and export this data going back to . Start your Free Trial

What is Vaxart 10-Year Share Buyback Ratio?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

10-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past ten years. It is calculated as the annualized percentage change in shares outstanding from ten years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. Vaxart's current 10-Year Share Buyback Ratio was -68.30%.

STU:NB11's 10-Year Share Buyback Ratio is ranked worse than
89.88% of 652 companies
in the Biotechnology industry
Industry Median: -12.2 vs STU:NB11: -68.30

Competitive Comparison of Vaxart's 10-Year Share Buyback Ratio

For the Biotechnology subindustry, Vaxart's 10-Year Share Buyback Ratio, along with its competitors' market caps and 10-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vaxart's 10-Year Share Buyback Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vaxart's 10-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Vaxart's 10-Year Share Buyback Ratio falls into.

Save Embed

;

Save Embed

;

Vaxart 10-Year Share Buyback Ratio Calculation

This is the annualized percentage change in shares outstanding from ten years ago to the current year. The annualized percentage change is calculated with least-square regression based on the eleven years of annual data on Shares Outstanding (EOP).

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Vaxart (STU:NB11) 10-Year Share Buyback Ratio Explanation

A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

Vaxart 10-Year Share Buyback Ratio Related Terms

Thank you for viewing the detailed overview of Vaxart's 10-Year Share Buyback Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Vaxart Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vaxart Inc (STU:NB11) » Definitions » 10-Year Share Buyback Ratio

Comparable Companies

Traded in Other Exchanges

VXRT:USA NB11:Germany

Address

170 Harbor Way, Suite 300, South San Francisco, CA, USA, 94080

Website

https://www.vaxart.com

Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines based on its Vector Adjuvant Antigen Standardized Technology to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.

Vaxart Headlines

No Headlines